Related Experiment Video
Updated: Feb 27, 2026
09:00
A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions
Published on: April 18, 2025
1.4K
The Roles of Matrix Metalloproteinases in Pancreatic Cancer
Anna M Knapinska1, Christie-Anne Estrada1, Gregg B Fields2
1Florida Atlantic University, Jupiter, FL, United States.
Summary
Matrix metalloproteinases (MMPs) are key in pancreatic cancer. While broad inhibitors failed, MT1-MMP is crucial for progression, and MMP-9 acts as an anti-target for therapy.
Area of Science:
- Oncology
- Cancer Biology
- Biochemistry
Background:
- Matrix metalloproteinases (MMPs) are implicated in cancer initiation, growth, and metastasis.
- Previous clinical trials with broad-spectrum MMP inhibitors in pancreatic cancer yielded discouraging results.
- A need exists for precise roles of individual MMPs and improved animal models for pancreatic cancer research.
Purpose of the Study:
- To delineate the specific roles of individual MMPs in pancreatic cancer progression.
- To evaluate the therapeutic potential of targeting specific MMPs in pancreatic cancer.
- To highlight advancements in understanding MMP functions and developing relevant preclinical models.
Main Methods:
- Review and synthesis of recent research on MMPs in pancreatic cancer.
- Analysis of preclinical data and clinical trial outcomes related to MMP inhibition.
- Focus on the roles of MT1-MMP and MMP-9 in pancreatic cancer pathogenesis.
Main Results:
- MT1-MMP (MMP-14) is identified as a critical mediator in multiple steps of pancreatic cancer progression.
- MMP-9 is suggested to be an "antitarget," indicating it may not be a suitable therapeutic target in pancreatic cancer.
- Progress has been made in defining specific MMP roles and developing more accurate animal models.
Conclusions:
- Targeting specific MMPs, like MT1-MMP, holds promise for pancreatic cancer therapy.
- MMP-9 should be reconsidered as a therapeutic target for pancreatic cancer.
- Further research focusing on individual MMPs and refined models is essential for effective pancreatic cancer treatment.
Related Concept Videos
01:23Role of Matrix Metalloproteases in Degradation of ECM
3.5K
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
3.5K
02:17The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
01:29The Extracellular Matrix
12.8K
Overview
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
12.8K
03:03mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
01:35Cancer Cell Migration through Invadopodia
3.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.4K